CA
NZ
UK
AU
IND
US
Kevin P. O'Shea, Chief Financial Officer of AvalonBay Communities, Inc. (NASDAQ:AVB), filed a Form 4 on August 17, 2026, reporting changes in beneficial ownership of common stock and employee stock options resulting from AvalonBay's merger with Equity Residential.
AvalonBay Communities, Inc. filed a Form 8-K with the SEC on August 17, 2026, reporting the completion of its merger with Vivmark Residential (formerly Equity Residential), with ERP Operating Partnership continuing as the surviving entity.
Illumina, Inc. filed an 8-K with the U.S. Securities and Exchange Commission on August 17, 2026, reporting the completion of a public offering of $300,000,000 aggregate principal amount of 4.950% notes due 2029.
Ardelyx, Inc. filed an 8-K on August 17, 2026 disclosing that Chief Commercial Officer Eric Foster notified the company of his resignation on August 11, 2026, with an effective date of August 28, 2026.
Motorola Solutions, Inc. filed a Form 8-K on August 17, 2026, disclosing the closing of an underwritten public offering of two tranches of senior notes totaling $950,000,000 in aggregate principal amount.
Repay Holdings Corporation filed a Form 8-K/A (Amendment No. 1) on August 17, 2026, amending its original June 1, 2026 Current Report to include required financial statements and unaudited pro forma financial information related to its completed acquisition of KUBRA Holdings, Inc. and KUBRA …
Fastly, Inc. filed a Form 8-K on August 17, 2026, disclosing that it entered into a Fourth Amendment to its Credit Agreement, increasing its senior secured revolving credit facility and extending its maturity date, among other changes.
IDEX Corporation filed a current report on August 17, 2026, disclosing that director L. Paris Watts-Stanfield resigned from its Board of Directors effective August 13, 2026, reducing the board from ten to nine members.
Horizon Bancorp, Inc. filed a Form 8-K on August 17, 2026, disclosing that its Board of Directors increased in size from 11 to 13 members and elected Nicholas J. Ritter and Charles W. Sulerzyski as independent directors to the Class of 2027.
Turn Therapeutics Inc. filed a Form 8-K on August 17, 2026, disclosing a private placement of common stock that closed under securities purchase agreements dated August 14, 2026.
Please wait processing your request...